Mitral Stenosis Is Almost Always the Late Consequence of Rheumatic Fever. Here Is When Balloon Valvotomy Is the Answer.

2. What It Is

Mitral stenosis (MS) is obstruction of the mitral valve orifice, impairing filling of the left ventricle from the left atrium during diastole. The normal mitral valve area is 4-6 cm2. Obstruction becomes clinically significant below 2.0 cm2.

Severity grading:

• Mild MS: MVA above 1.5 cm2, mean gradient below 5 mmHg, pulmonary artery systolic pressure (PASP) below 30 mmHg
• Moderate MS: MVA 1.0-1.5 cm2, mean gradient 5-10 mmHg
• Severe MS: MVA below 1.5 cm2 with symptoms, mean gradient above 10 mmHg, or PASP above 50 mmHg 5 / Solid

Very severe MS: MVA below 1.0 cm2.

Causes

Rheumatic heart disease is the dominant cause worldwide, responsible for over 90% of MS globally 5 / Solid 00242-X). Rheumatic fever is a complication of Group A streptococcal (GAS) pharyngitis, triggering autoimmune inflammation that damages cardiac valves. The mitral valve is the most commonly and severely affected. Repeated episodes of rheumatic fever (common in areas without prompt antibiotic treatment of strep pharyngitis) produce progressive valve damage over years.

In the United States, rheumatic MS is primarily a disease of immigrants from sub-Saharan Africa, South Asia, Latin America, and Southeast Asia, where rheumatic fever remains endemic. For the clinical picture of rheumatic heart disease in immigrant men and the diagnostic gaps that leave it unrecognized, see the full discussion. Native-born Americans rarely develop rheumatic MS unless they grew up in a developing country. The US clinician who does not think about rheumatic MS in an immigrant patient presenting with dyspnea and AF is making an avoidable diagnostic error.

Calcific (degenerative) MS: Severe mitral annular calcification extending to the base of the leaflets can narrow the valve orifice in elderly patients. This is distinct from rheumatic MS in anatomy (annular rather than commissural) and in interventional approach (PBMV is not applicable; surgery is more challenging; transcatheter mitral valve replacement is being evaluated for this group).

Congenital MS: Rare; caused by supravalvular mitral ring, parachute mitral valve, or hypoplastic annulus.

3. The Mechanism

The mitral valve as a diastolic “funnel”

In rheumatic MS, the commissural fusion (thickening and scarring of the leaflet edges where anterior and posterior leaflets meet) reduces the effective valve opening area. The subvalvular apparatus (chordae tendineae, papillary muscles) is also thickened, shortened, and fused, contributing to additional subvalvular obstruction.

Because the LV fills only during diastole, the obstructed mitral valve forces the LA to generate progressively higher pressure to push blood through the narrowed orifice. This raised LA pressure is transmitted backward into the pulmonary veins, pulmonary capillaries, and pulmonary arteries.

The hemodynamic consequences cascade:

1. Raised pulmonary capillary wedge pressure leads to exertional dyspnea
2. Progressive pulmonary hypertension (reactive, from chronic venous pressure elevation) develops over years
3. RV pressure overload from pulmonary hypertension leads to RV dilation and eventually right heart failure
4. LA dilation (from chronic pressure and volume overload) provides the substrate for AF
5. AF with rapid ventricular response acutely worsens MS hemodynamics by shortening diastolic filling time: the shorter the diastole, the less time for the stenotic valve to fill the LV, and the more precipitously LA pressure rises

The heart rate-dependence of MS is unique among valve diseases. In a normal heart, faster heart rate is compensated by faster filling. In MS, faster heart rate means less time per beat for the LV to fill through the obstructed valve: cardiac output falls and LA pressure spikes. This is why AF with rapid rate triggers acute pulmonary edema in MS patients, and why rate control (not rhythm control alone) is the immediate priority.

4. How We Diagnose

Auscultation

Classic MS findings:

• Loud S1: The stenotic, restricted mitral leaflets close with the LV filling pressure pushing them shut forcefully; S1 is accentuated (until the valve becomes heavily calcified and immobile, at which point S1 becomes soft)
• Opening snap (OS): A high-pitched sound in early diastole, occurring when the mitral valve reaches the limit of its restricted opening movement; the shorter the interval between S2 and OS (A2-OS interval), the more severe the stenosis
• Low-pitched diastolic rumble: Heard with the bell of the stethoscope at the apex, in the left lateral decubitus position, beginning after the OS and lasting through diastole; presystolic accentuation (louder just before S1) if the patient is in sinus rhythm

The S2-OS interval is the bedside analog to pressure gradient: a short S2-OS (less than 70 ms) indicates high LA pressure and severe MS. This observation requires a quiet room and experience.

Echocardiography

TTE provides:

• Mitral valve area (MVA) by planimetry (direct area measurement in short-axis view) and by pressure half-time (PHT) method: MVA = 220 / PHT. Note: PHT method is unreliable in AR (which affects LV diastolic pressure) and after valvuloplasty.
• Mean transmitral gradient (the primary hemodynamic severity parameter; should be measured with attention to heart rate, as gradient is heart rate-dependent)
• Wilkins score (leaflet thickening, leaflet mobility, subvalvular thickening, calcification): each scored 0-4; total above 8 predicts higher risk of inadequate PBMV result
• Left atrial size and presence of thrombus (particularly in the LA appendage)
• Pulmonary artery systolic pressure
• Presence and severity of mitral regurgitation (excluding patients with more than trace-mild MR from PBMV, because the procedure can worsen MR)

TEE: required before PBMV to exclude LA appendage thrombus (a contraindication to PBMV). Also useful for detailed subvalvular assessment and to guide the transseptal puncture during the procedure.

Exercise hemodynamics

For patients with apparently mild or moderate MS at rest who report severe exertional symptoms, exercise Doppler echocardiography or exercise right heart catheterization can demonstrate a dramatic rise in mean gradient and pulmonary pressure with exertion. This “exercise-unmasked” severe MS is an indication for intervention in the 2021 guidelines when PASP exceeds 60 mmHg on exercise 5 / Solid .

5. The Evidence

PBMV: the Wilkins score framework

Percutaneous balloon mitral valvuloplasty is the preferred intervention for symptomatic severe MS with favorable valve anatomy. The Wilkins score predicts PBMV outcome: a score of 8 or below predicts an acceptable result (valve area increase to above 1.5 cm2, with low risk of significant MR). A score above 8 predicts an inadequate result or higher MR risk.

The NHLBI PBMV registry documented outcomes in over 4,800 patients: immediate valve area improvement from approximately 1.0 cm2 to 2.0 cm2, with 5-year event-free survival (freedom from death, repeat intervention, or NYHA Class III-IV symptoms) of approximately 60% 5 / Solid .

PBMV is a catheter-based procedure: femoral vein access, transseptal puncture, advancement of a balloon catheter across the mitral valve, and inflation of the balloon to split the fused commissures. A well-executed PBMV can produce results equivalent to surgical commissurotomy.

Long-term outcomes: Fawzy series (2007)

Fawzy ME, et al., JACC 2007 (10.1016/j.jacc.2006.09.059) followed 520 patients after successful PBMV for up to 20 years. Freedom from restenosis was approximately 75% at 10 years and 50% at 20 years in patients with low Wilkins scores 5 / Solid . Predictors of restenosis: higher Wilkins score, larger residual mitral gradient, younger age (longer lifetime of the native valve after valvuloplasty). This is the best long-term data for PBMV durability.

Surgical commissurotomy vs PBMV

Open surgical commissurotomy under cardiopulmonary bypass allows direct visualization and more complete splitting of fused commissures, including subvalvular apparatus release. The Ben Farhat randomized trial (Circulation 1998; 10.1161/01.CIR.97.3.245) showed similar 7-year outcomes for closed commissurotomy, open commissurotomy, and PBMV in favorable anatomy patients 5 / Solid . PBMV is preferred when anatomy is favorable (Wilkins score 8 or below) due to avoiding open-heart surgery. Surgery is preferred for: unfavorable anatomy, significant concomitant MR, need for other cardiac surgery simultaneously, or inability to perform transseptal access safely.

Mitral valve replacement is reserved for patients with failed PBMV, severe subvalvular disease making commissurotomy or valvuloplasty impossible, or severe concomitant MR. Replacing the native mitral valve requires either a mechanical prosthesis (with lifelong anticoagulation) or a bioprosthetic valve (with durability limitations in younger patients).

Anticoagulation in MS with AF

The thromboembolic risk in MS is substantially higher than AF alone: the combination of an enlarged LA, low-flow state from the stenotic valve, and AF (loss of organized atrial contraction, appendage stasis) creates a highly thrombogenic milieu. LA appendage thrombus is found in 20-30% of patients with MS and AF at the time of TEE 5 / Solid 00967-9). Warfarin (INR 2.0-3.0) is the recommended anticoagulant for MS with AF 5 / Solid . The data for direct oral anticoagulants (DOACs) in moderate-severe MS is limited; DOAC trials excluded MS patients. The 2019 INVICTUS trial comparing rivaroxaban versus warfarin in rheumatic AF (predominantly from rheumatic MS and MR) showed warfarin was superior to rivaroxaban for reduction of stroke and vascular death 5 / Solid . Warfarin remains the standard for MS with AF.

6. The Patient Experience

Rheumatic MS in the immigrant patient in the United States is a story of diagnostic delay, access barriers, and a disease that the American healthcare system was built to miss. Group A streptococcal pharyngitis is treated within 24-48 hours in the United States; rheumatic fever from untreated strep throat is rare in American-born patients. But a patient who grew up in Ethiopia, India, Peru, or the Philippines may have had multiple episodes of rheumatic fever before age 20, with progressive mitral valve damage accumulating silently.

By the time this patient presents to an American emergency department with AF and heart failure symptoms at age 45-55, the mitral stenosis has been present for decades. The structural damage is established. The intervention is still possible and can be life-extending, but the opportunity for primary prevention has passed.

The secondary prevention story for rheumatic MS is penicillin prophylaxis. After the first episode of rheumatic fever, monthly penicillin injections for 10 years (or through age 21 in children) reduce the risk of recurrent strep infections and additional valve damage. In the United States, immigrant patients with known prior rheumatic fever should be offered ongoing prophylaxis until age 25 or 10 years after the most recent episode 5 / Solid . This intervention is rarely implemented because the diagnosis of prior rheumatic fever is rarely documented in the American chart.

Post-PBMV experience: the procedure itself is performed under fluoroscopy and echocardiographic guidance. Duration is approximately 2-3 hours. Most patients notice immediate improvement in dyspnea from the reduction in LA pressure. Hospital stay is 1-2 days. Activity restrictions for 1-2 weeks. The improvement in effort tolerance can be dramatic: a patient who could not walk more than half a block may be walking miles within a month.

7. Decisions and Trade-Offs

PBMV suitability: the Wilkins score in practice

The Wilkins score (each criterion 0-4, maximum 16):

• Leaflet mobility: 1 = highly mobile; 4 = no visible motion
• Subvalvular thickening: 1 = minimal; 4 = severe
• Leaflet thickening: 1 = near-normal; 4 = very thick
• Calcification: 1 = single area; 4 = extensive

Wilkins below 8: favorable for PBMV, expected good result with low MR risk. Wilkins 8-10: borderline; PBMV may be attempted with careful monitoring for MR during the procedure. Wilkins above 10: unfavorable; surgery is preferred.

The Massachusetts General Hospital (MGH) score and the Cormier score are alternative scoring systems used by different centers. The basic principle is the same: leaflet flexibility predicts commissural splitting, and calcification predicts MR risk.

Rate vs rhythm control in MS

In MS with AF, both rate control and rhythm control are used, but the rationale is different from non-MS AF. Rate control is the immediate priority because slowing heart rate lengthens diastolic filling time, reducing the transmitral gradient and LA pressure. Target heart rate below 70-80 bpm at rest.

Rhythm control (cardioversion or AF ablation) is secondary. If the patient undergoes PBMV and the LA is not yet severely dilated (below 5 cm), cardioversion to sinus rhythm post-PBMV is reasonable; sinus rhythm restoration reduces stroke risk and may improve hemodynamics. For patients with severely dilated LA (above 5.5-6 cm) and long-standing AF, sinus rhythm restoration is unlikely to be durable.

When MS coexists with AR or MR

Rheumatic heart disease commonly affects multiple valves simultaneously. The combination of MS and MR is the most common multi-valve rheumatic presentation. If MR is more than mild, PBMV is contraindicated because commissural splitting often worsens MR. Surgery addressing both valves is required. The cardiothoracic surgical teams at Northwestern Memorial (Chicago), Rush University Medical Center (Chicago), and Loyola University Medical Center (Maywood, IL) manage complex multi-valve rheumatic disease.

Clinical Synthesis

Mitral stenosis in the United States is a disease of unmet clinical recognition. The clinical system was not built to screen immigrant populations for rheumatic valve disease, and the disease is rare enough in native-born Americans that it falls below clinical suspicion thresholds for most emergency medicine physicians and internists.

The cardiovascular assessment’s role in this context: for immigrant patients from rheumatic fever-endemic countries presenting for any cardiovascular evaluation, the Audit protocol includes specific mitral valve morphology assessment beyond routine echocardiographic screening. A patient from sub-Saharan Africa, South Asia, or South America with unexplained dyspnea, AF, or an unexplained systolic or diastolic murmur should have a TEE if the TTE is non-diagnostic.

For the patient from Rogers Park: this model would have flagged her at her second AF presentation for mitral valve structural assessment. Four emergency visits over several years, each managing the downstream AF without identifying the upstream valve disease, is a system failure that costs patients years of appropriate management.

Once diagnosed, MS with favorable anatomy (Wilkins below 8) and symptoms is a condition where a single interventional procedure (PBMV) can restore near-normal mitral valve function and dramatically improve quality of life. A cardiologist-led preventive program facilitates referral to the structural heart programs at Rush University, Northwestern, and University of Chicago for PBMV evaluation and procedure.

The woman from Rogers Park underwent PBMV at Rush University Medical Center. MVA opened from 1.1 cm2 to 2.1 cm2. Mean gradient fell from 14 mmHg to 5 mmHg. Her AF persisted but converted easily at cardioversion three months post-procedure; sinus rhythm was maintained on flecainide. At six months, she is walking two miles daily in Lincoln Park. She was not walking to the corner when she presented.

The rheumatic fever that damaged her valve happened in a childhood without access to penicillin. The intervention that restored her mobility happened in a tertiary cardiac center in Chicago. The distance between those two realities is the gap that equitable cardiology care exists to close. Identifying the disease in the first place is the first obligation. The structural heart program handles what follows.

The Signal Check is fifteen questions mapping the cardiovascular risk pattern across the physiological domains most commonly missed in standard screenings. It produces a specific starting point for your next clinical conversation.